Back to top
more

Guardant Health (GH)

(Delayed Data from NSDQ)

$17.35 USD

17.35
697,962

+0.19 (1.11%)

Updated Apr 26, 2024 04:00 PM ET

After-Market: $17.36 +0.01 (0.06%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value F Growth D Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 30% (76 out of 252)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for GH

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Fiscal Year End for Guardant Health, Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 1,169 1,011 933 1,795 523
Receivables 89 97 98 53 48
Notes Receivable 0 0 0 0 0
Inventories 62 52 31 23 15
Other Current Assets 28 32 53 17 11
Total Current Assets 1,347 1,192 1,114 1,888 597
Net Property & Equipment 145 168 124 63 44
Investments & Advances 0 0 698 247 269
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 12 15 18 19 19
Deposits & Other Assets 124 61 61 17 5
Total Assets 1,786 1,610 2,205 2,272 963
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 188 176 18 7 16
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 0 0 88 51 44
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 18 17 89 9 12
Total Current Liabilities 206 193 195 67 73
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 0 0
Convertible Debt 0 0 0 0 0
Long-Term Debt 1,140 1,137 1,135 806 0
Non-Current Capital Leases 0 0 0 0 33
Other Non-Current Liabilities 96 9 4 59 58
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 1,628 1,550 1,559 973 164
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 2,304 1,742 1,658 1,902 1,150
Retained Earnings -2,142 -1,662 -1,008 -607 -353
Other Equity -4 -20 -5 3 1
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 159 60 645 1,299 798
Total Liabilities & Shareholder's Equity 1,786 1,610 2,205 2,272 963
Total Common Equity 159 60 645 1,299 798
Shares Outstanding 117.90 102.40 101.60 99.90 93.90
Book Value Per Share 1.35 0.59 6.35 13.00 8.50

Fiscal Year End for Guardant Health, Inc falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 1,169 1,155 1,225 937
Receivables NA 89 89 86 87
Notes Receivable NA 0 0 0 0
Inventories NA 62 77 61 46
Other Current Assets NA 28 26 26 34
Total Current Assets NA 1,347 1,347 1,398 1,104
Net Property & Equipment NA 145 148 156 163
Investments & Advances NA 0 0 0 0
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 0 0 0
Intangibles NA 12 13 14 14
Deposits & Other Assets NA 124 128 108 59
Total Assets NA 1,786 1,797 1,840 1,512
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA 0 0 0 0
Accounts Payable NA 188 205 189 191
Current Portion Long-Term Debt NA 0 0 0 0
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 0 0 0 0
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 18 21 12 14
Total Current Liabilities NA 206 227 201 204
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 0 0 0 0
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 1,140 1,139 1,139 1,138
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 10 9 9
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 1,628 1,569 1,547 1,556
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 0 0 0 0
Capital Surplus NA 2,304 2,189 2,170 1,764
Retained Earnings NA -2,142 -1,955 -1,869 -1,796
Other Equity NA -4 -6 -8 -12
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 159 228 293 -45
Total Liabilities & Shareholder's Equity NA 1,786 1,797 1,840 1,512
Total Common Equity 0 159 228 293 -45
Shares Outstanding 121.70 117.90 117.60 117.60 102.70
Book Value Per Share 0.00 1.35 1.94 2.49 -0.43